GlassScriptPhysician profile
Ryan Jameson
NPI 1164107959
$7,259.43
in general payments reported to CMS, 2019-2025
19 companies · $5,429 in 2025
The $5,429 reported for 2025 was more than what 96% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $509 · 2024: $1,322 · 2025: $5,429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,209 · Travel and Lodging: $3,050.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,209.27 |
| Travel and Lodging | $3,050.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $2,986.23 | 2023-2025 | Motoband, Na, Fibergraft Aeridyan Matrix |
| Stryker Corporation | $1,349.25 | 2023-2025 | Infinity Adaptis, Infinity, Augment Injectable |
| Medical Device Business Services, INC. | $748.01 | 2025 | Motoband |
| Kerecis Limited | $363.50 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Smith+Nephew, INC. | $347.36 | 2024-2025 | Oasis, Stravix, Grafix |
| Organogenesis INC. | $283.20 | 2025 | Puraply Wound Matrix |
| Sioux Surgical INC | $177.73 | 2023-2025 | |
| Sanara Medtech INC. | $177.52 | 2025 | Celleraterx |
| Paragon 28, INC. | $167.25 | 2024-2025 | Additive Orthopedics, Phantom Fibula Nail |
| My01 INC. | $137.28 | 2025 | My01 Continuous Compartmental Pressure Monitor |
| Integra Lifesciences Corporation | $124.91 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| International Life Sciences | $109.84 | 2024 | Flexband |
| Access Pro Medical, LLC | $96.34 | 2025 | Matriderm |
| Avita Medical Americas, LLC | $95.11 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $23.12 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $22.30 | 2024 | Tapestry |
| Solventum Corporation | $19.18 | 2024 | Prevena Restor Arthroform, V.A.C. Veraflo |
| Paratek Pharmaceuticals, INC. | $16.02 | 2024 | Nuzyra |
| Polynovo North America LLC | $15.28 | 2024 | Novosorb Btm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Jameson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.